Enterprise Value, page-126

@avetis
Will keep an eye on any updates for the vitiligo final data collection date over the coming months.

Another ongoing clinical trial that might be flying under the radar, after the FDA approved full thickness burns for pediatric patients and recruitment stopped, is partial-thickness burns in ages 1-16 years (pediatric scalds).

The final data collection date for primary outcome measure is estimated to be June 30, 2022. Add the 3 months and results could be announced in September.



https://clinicaltrials.gov/ct2/show/record/NCT03626701?term=Recell&draw=2

In summary, it's possible that the company could announce clinical trial results for:

• Soft Tissue Reconstruction - June 2022
• Repigmentation of Stable Vitiligo Lesions - September 2022
• Partial-thickness Burns in Ages 1-16 Years - September 2022

Positive trial results combined with some decent revenue growth would be nice to see this year.